Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Akshay Suvas Desai, M.D.

Title
Institution
Department
Address
Phone
Fax
Profile Picture

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Dewan P, Jackson A, Jhund PS, Shen L, Ferreira JP, Petrie MC, Abraham WT, Desai AS, Dickstein K, Køber L, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, McMurray JJV. The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE. Eur J Heart Fail. 2020 Apr 30. PMID: 32353205.
    Citations:    
  2. Almufleh A, Desai AS, Fay R, Ferreira JP, Buckley LF, Mehra MR, Rossignol P, Zannad F. Correlation of laboratory haemoconcentration measures with filling pressures obtained via pulmonary arterial pressure sensors in ambulatory heart failure patients. Eur J Heart Fail. 2020 Apr 30. PMID: 32353199.
    Citations:    
  3. Buckley LF, Cheng JWM, Desai A. Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin Converting Enzyme 2. J Cardiovasc Pharmacol. 2020 Apr 13. PMID: 32301766.
    Citations:    
  4. Docherty KF, Jhund PS, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, Ponikowski P, DeMets DL, Sabatine MS, Bengtsson O, Sjöstrand M, Langkilde AM, Desai AS, Diez M, Howlett JG, Katova T, Ljungman CEA, O'Meara E, Petrie MC, Schou M, Verma S, Vinh PN, Solomon SD, McMurray JJV. Effects of dapagliflozin in DAPA-HF according to background heart failure therapy. Eur Heart J. 2020 Mar 28. PMID: 32221582.
    Citations:    
  5. Petrie MC, Verma S, Docherty KF, Inzucchi SE, Anand I, Belohlávek J, Böhm M, Chiang CE, Chopra VK, de Boer RA, Desai AS, Diez M, Drozdz J, Dukát A, Ge J, Howlett J, Katova T, Kitakaze M, Ljungman CEA, Merkely B, Nicolau JC, O'Meara E, Vinh PN, Schou M, Tereshchenko S, Køber L, Kosiborod MN, Langkilde AM, Martinez FA, Ponikowski P, Sabatine MS, Sjöstrand M, Solomon SD, Johanson P, Greasley PJ, Boulton D, Bengtsson O, Jhund PS, McMurray JJV. Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes. JAMA. 2020 Mar 27. PMID: 32219386.
    Citations:    
  6. Rørth R, Jhund PS, Yilmaz MB, Kristensen SL, Welsh P, Desai AS, Køber L, Prescott MF, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJV. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction. Circ Heart Fail. 2020 Feb; 13(2):e006541. PMID: 32065760.
    Citations:    
  7. Simpson J, Jhund PS, Lund LH, Padmanabhan S, Claggett BL, Shen L, Petrie MC, Abraham WT, Desai AS, Dickstein K, Køber L, Packer M, Rouleau JL, Mueller-Velten G, Solomon SD, Swedberg K, Zile MR, McMurray JJV. Prognostic Models Derived in PARADIGM-HF and Validated in ATMOSPHERE and the Swedish Heart Failure Registry to Predict Mortality and Morbidity in Chronic Heart Failure. JAMA Cardiol. 2020 Jan 29. PMID: 31995119.
    Citations:    
  8. Myhre PL, Vaduganathan M, O'Meara E, Claggett BL, de Denus S, Jarolim P, Anand IS, Pitt B, Rouleau JL, Solomon SD, Pfeffer MA, Desai AS. Mechanistic Effects of Spironolactone on Cardiovascular and Renal Biomarkers in Heart Failure With Preserved Ejection Fraction: A TOPCAT Biorepository Study. Circ Heart Fail. 2020 Jan; 13(1):e006638. PMID: 31957468.
    Citations:    
  9. Slavin SD, Allen LA, McIlvennan CK, Desai AS, Schaefer KG, Warraich HJ. Left Ventricular Assist Device Withdrawal: Ethical, Psychological, and Logistical Challenges. J Palliat Med. 2020 Apr; 23(4):456-458. PMID: 31895635.
    Citations:    
  10. Docherty KF, Shen L, Castagno D, Petrie MC, Abraham WT, Böhm M, Desai AS, Dickstein K, Køber LV, Packer M, Rouleau JL, Solomon SD, Swedberg K, Vazir A, Zile MR, Jhund PS, McMurray JJV. Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction. Eur J Heart Fail. 2020 Mar; 22(3):528-538. PMID: 31849164.
    Citations:    
  11. Dewan P, Rørth R, Raparelli V, Campbell RT, Shen L, Jhund PS, Petrie MC, Anand IS, Carson PE, Desai AS, Granger CB, Køber L, Komajda M, McKelvie RS, O'Meara E, Pfeffer MA, Pitt B, Solomon SD, Swedberg K, Zile MR, McMurray JJV. Sex-Related Differences in Heart Failure With Preserved Ejection Fraction. Circ Heart Fail. 2019 Dec; 12(12):e006539. PMID: 31813280.
    Citations:    
  12. Vardeny O, Claggett B, Vaduganathan M, Beldhuis I, Rouleau J, O'Meara E, Anand IS, Shah SJ, Sweitzer NK, Fang JC, Desai AS, Lewis EF, Pitt B, Pfeffer MA, Solomon SD. Influence of Age on Efficacy and Safety of Spironolactone in Heart Failure. JACC Heart Fail. 2019 Dec; 7(12):1022-1028. PMID: 31779923.
    Citations:    
  13. Chuzi S, Pak ES, Desai AS, Schaefer KG, Warraich HJ. Role of Palliative Care in the Outpatient Management of the Chronic Heart Failure Patient. Curr Heart Fail Rep. 2019 12; 16(6):220-228. PMID: 31792699.
    Citations:    
  14. Solomon SD, Vaduganathan M, L Claggett B, Packer M, Zile M, Swedberg K, Rouleau J, A Pfeffer M, Desai A, H Lund L, Kober L, Anand I, Sweitzer N, Linssen G, Merkely B, Luis Arango J, Vinereanu D, Chen CH, Senni M, Sibulo A, Boytsov S, Shi V, Rizkala A, Lefkowitz M, McMurray JJV. Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure. Circulation. 2020 Feb 04; 141(5):352-361. PMID: 31736342.
    Citations:    
  15. Blood AJ, Fischer CM, Fera LE, MacLean TE, Smith KV, Dunning JR, Bosque-Hamilton JW, Aronson SJ, Gaziano TA, MacRae CA, Matta LS, Mercurio-Pinto AA, Murphy SN, Scirica BM, Wagholikar K, Desai AS. Rationale and design of a navigator-driven remote optimization of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction. Clin Cardiol. 2020 Jan; 43(1):4-13. PMID: 31725920.
    Citations:    
  16. Vaduganathan M, Claggett BL, Desai AS, Anker SD, Perrone SV, Janssens S, Milicic D, Arango JL, Packer M, Shi VC, Lefkowitz MP, McMurray JJV, Solomon SD. Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared With Valsartan in HFpEF. J Am Coll Cardiol. 2020 Jan 28; 75(3):245-254. PMID: 31726194.
    Citations:    
  17. Buckley LF, Stevenson LW, Cooper IM, Knowles DM, Matta L, Molway DW, Navarro-Velez K, Rhoten MN, Shea EL, Stern GM, Weintraub JR, Young MA, Mehra MR, Desai AS. Ambulatory Treatment of Worsening Heart Failure With Intravenous Loop Diuretics: A Four-Year Experience. J Card Fail. 2019 Nov 05. PMID: 31704197.
    Citations:    
  18. Castro RRT, Joyce E, Lakdawala NK, Stewart G, Nohria A, Givertz MM, Desai A, Lewis EF, Stevenson LW. Patients report more severe daily limitations than recognized by their physicians. Clin Cardiol. 2019 Dec; 42(12):1181-1188. PMID: 31571248.
    Citations:    
  19. McMurray JJV, Solomon SD, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, Belohlávek J, Böhm M, Chiang CE, Chopra VK, de Boer RA, Desai AS, Diez M, Drozdz J, Dukát A, Ge J, Howlett JG, Katova T, Kitakaze M, Ljungman CEA, Merkely B, Nicolau JC, O'Meara E, Petrie MC, Vinh PN, Schou M, Tereshchenko S, Verma S, Held C, DeMets DL, Docherty KF, Jhund PS, Bengtsson O, Sjöstrand M, Langkilde AM. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2019 11 21; 381(21):1995-2008. PMID: 31535829.
    Citations:    
  20. Selvaraj S, Claggett B, Pozzi A, McMurray JJV, Jhund PS, Packer M, Desai AS, Lewis EF, Vaduganathan M, Lefkowitz MP, Rouleau JL, Shi VC, Zile MR, Swedberg K, Solomon SD. Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HF. Circulation. 2019 Oct 22; 140(17):1369-1379. PMID: 31510768.
    Citations:    
  21. Desai AS, Solomon SD, Shah AM, Claggett BL, Fang JC, Izzo J, McCague K, Abbas CA, Rocha R, Mitchell GF. Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial. JAMA. 2019 Sep 02; 1-10. PMID: 31475296.
    Citations:    
  22. Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, van Veldhuisen DJ, Zannad F, Zile MR, Desai AS, Claggett B, Jhund PS, Boytsov SA, Comin-Colet J, Cleland J, Düngen HD, Goncalvesova E, Katova T, Kerr Saraiva JF, Lelonek M, Merkely B, Senni M, Shah SJ, Zhou J, Rizkala AR, Gong J, Shi VC, Lefkowitz MP. Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. N Engl J Med. 2019 10 24; 381(17):1609-1620. PMID: 31475794.
    Citations:    
  23. Dunlay SM, Givertz MM, Aguilar D, Allen LA, Chan M, Desai AS, Deswal A, Dickson VV, Kosiborod MN, Lekavich CL, Mccoy RG, Mentz RJ, Pina IL. Corrigendum to "Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America" Journal of Cardiac Failure Vol. 25 No. 8, pp. 584-619. J Card Fail. 2019 Oct; 25(10):851. PMID: 31444147.
    Citations:    
  24. Tromp J, Shen L, Jhund PS, Anand IS, Carson PE, Desai AS, Granger CB, Komajda M, McKelvie RS, Pfeffer MA, Solomon SD, Køber L, Swedberg K, Zile MR, Pitt B, Lam CSP, McMurray JJV. Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol. 2019 08 06; 74(5):601-612. PMID: 31370950.
    Citations:    
  25. Myhre PL, Vaduganathan M, Claggett BL, Lam CSP, Desai AS, Anand IS, Sweitzer NK, Fang JC, O'Meara E, Shah SJ, Shah AM, Lewis EF, Rouleau J, Pitt B, Solomon SD. Application of the H2 FPEF score to a global clinical trial of patients with heart failure with preserved ejection fraction: the TOPCAT trial. Eur J Heart Fail. 2019 Oct; 21(10):1288-1291. PMID: 31332920.
    Citations:    
  26. Minamisawa M, Seidelmann SB, Claggett B, Hegde SM, Shah AM, Desai AS, Lewis EF, Shah SJ, Sweitzer NK, Fang JC, Anand IS, O'Meara E, Rouleau JL, Pitt B, Solomon SD. Impact of Malnutrition Using Geriatric Nutritional Risk Index in Heart Failure With Preserved Ejection Fraction. JACC Heart Fail. 2019 Aug; 7(8):664-675. PMID: 31302049.
    Citations:    
  27. Selvaraj S, Claggett B, Shah SJ, Anand IS, Rouleau JL, Desai AS, Lewis EF, Vaduganathan M, Wang SY, Pitt B, Sweitzer NK, Pfeffer MA, Solomon SD. Utility of the Cardiovascular Physical Examination and Impact of Spironolactone in Heart Failure With Preserved Ejection Fraction. Circ Heart Fail. 2019 07; 12(7):e006125. PMID: 31220936.
    Citations:    
  28. Divakaran S, Stewart GC, Lakdawala NK, Padera RF, Zhou W, Desai AS, Givertz MM, Mehra MR, Kwong RY, Hedgire SS, Ghoshhajra BB, Taqueti VR, Skali H, Dorbala S, Blankstein R, Di Carli MF. Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis. Circ Cardiovasc Imaging. 2019 06; 12(6):e008975. PMID: 31177817.
    Citations:    
  29. Dunlay SM, Givertz MM, Aguilar D, Allen LA, Chan M, Desai AS, Deswal A, Dickson VV, Kosiborod MN, Lekavich CL, McCoy RG, Mentz RJ, Piña IL. Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update. Circulation. 2019 08 13; 140(7):e294-e324. PMID: 31167558.
    Citations:    
  30. Dunlay SM, Givertz MM, Aguilar D, Allen LA, Chan M, Desai AS, Deswal A, Dickson VV, Kosiborod MN, Lekavich CL, McCoy RG, Mentz RJ, PiÑa IL. Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America. J Card Fail. 2019 Aug; 25(8):584-619. PMID: 31174952.
    Citations:    
  31. Abraham J, Bharmi R, Jonsson O, Oliveira GH, Artis A, Valika A, Capodilupo R, Adamson PB, Roberts G, Dalal N, Desai AS, Benza RL. Association of Ambulatory Hemodynamic Monitoring of Heart Failure With Clinical Outcomes in a Concurrent Matched Cohort Analysis. JAMA Cardiol. 2019 Jun 01; 4(6):556-563. PMID: 31090869.
    Citations:    
  32. Cappola AR, Desai AS, Medici M, Cooper LS, Egan D, Sopko G, Fishman GI, Goldman S, Cooper DS, Mora S, Kudenchuk PJ, Hollenberg AN, McDonald CL, Ladenson PW. Thyroid and Cardiovascular Disease Research Agenda for Enhancing Knowledge, Prevention, and Treatment. Circulation. 2019 May 13. PMID: 31081673.
    Citations:    
  33. Cappola AR, Desai AS, Medici M, Cooper LS, Egan D, Sopko G, Fishman GI, Goldman S, Cooper DS, Mora S, Kudenchuk PJ, Hollenberg AN, McDonald CL, Ladenson PW. Thyroid and Cardiovascular Disease: Research Agenda for Enhancing Knowledge, Prevention, and Treatment. Thyroid. 2019 06; 29(6):760-777. PMID: 31081722.
    Citations:    
  34. Wagholikar KB, Fischer CM, Goodson AP, Herrick CD, Maclean TE, Smith KV, Fera L, Gaziano TA, Dunning JR, Bosque-Hamilton J, Matta L, Toscano E, Richter B, Ainsworth L, Oates MF, Aronson S, MacRae CA, Scirica BM, Desai AS, Murphy SN. Phenotyping to Facilitate Accrual for a Cardiovascular Intervention. J Clin Med Res. 2019 Jun; 11(6):458-463. PMID: 31143314.
    Citations:    
  35. Morrow DA, Velazquez EJ, DeVore AD, Desai AS, Duffy CI, Ambrosy AP, Gurmu Y, McCague K, Rocha R, Braunwald E. Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial. Circulation. 2019 05 07; 139(19):2285-2288. PMID: 30955360.
    Citations:    
  36. Lindenfeld J, Abraham WT, Maisel A, Zile M, Smart F, Costanzo MR, Mehra MR, Ducharme A, Sears SF, Desai AS, Paul S, Sood P, Johnson N, Ginn G, Adamson PB. Hemodynamic-GUIDEd management of Heart Failure (GUIDE-HF). Am Heart J. 2019 08; 214:18-27. PMID: 31150790.
    Citations:    
  37. Desai AS, Mc Causland FR. Urinary Sodium as a Heart Failure Biomarker: More Complicated Than it Seems. JACC Heart Fail. 2019 May; 7(5):415-417. PMID: 31047022.
    Citations:    
  38. Shen L, Jhund PS, Docherty KF, Petrie MC, Anand IS, Carson PE, Desai AS, Granger CB, Komajda M, McKelvie RS, Pfeffer MA, Solomon SD, Swedberg K, Zile MR, McMurray JJV. Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction. JACC Heart Fail. 2019 May; 7(5):418-427. PMID: 30981744.
    Citations:    
  39. Kato ET, Silverman MG, Mosenzon O, Zelniker TA, Cahn A, Furtado RHM, Kuder J, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Bonaca MP, Ruff CT, Desai AS, Goto S, Johansson PA, Gause-Nilsson I, Johanson P, Langkilde AM, Raz I, Sabatine MS, Wiviott SD. Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus. Circulation. 2019 05 28; 139(22):2528-2536. PMID: 30882238.
    Citations:    
  40. Vest AR, Chan M, Deswal A, Givertz MM, Lekavich C, Lennie T, Litwin SE, Parsly L, Rodgers JE, Rich MW, Schulze PC, Slader A, Desai A. Nutrition, Obesity, and Cachexia in Patients With Heart Failure: A Consensus Statement from the Heart Failure Society of America Scientific Statements Committee. J Card Fail. 2019 May; 25(5):380-400. PMID: 30877038.
    Citations:    
  41. Myhre PL, Vaduganathan M, Claggett B, Packer M, Desai AS, Rouleau JL, Zile MR, Swedberg K, Lefkowitz M, Shi V, McMurray JJV, Solomon SD. B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial. J Am Coll Cardiol. 2019 03 26; 73(11):1264-1272. PMID: 30846338.
    Citations:    
  42. Kristensen SL, Mogensen UM, Jhund PS, Rørth R, Anand IS, Carson PE, Desai AS, Pitt B, Pfeffer MA, Solomon SD, Zile MR, Køber L, McMurray JJV. N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status. Circ Heart Fail. 2019 03; 12(3):e005766. PMID: 30871349.
    Citations:    
  43. Vardeny O, Claggett B, Kachadourian J, Desai AS, Packer M, Rouleau J, Zile MR, Swedberg K, Lefkowitz M, Shi V, McMurray JJV, Solomon SD. Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial. Eur J Heart Fail. 2019 03; 21(3):337-341. PMID: 30741494.
    Citations:    
  44. Dewan P, Rørth R, Jhund PS, Ferreira JP, Zannad F, Shen L, Køber L, Abraham WT, Desai AS, Dickstein K, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, McMurray JJV. Income Inequality and Outcomes in Heart Failure: A Global Between-Country Analysis. JACC Heart Fail. 2019 04; 7(4):336-346. PMID: 30738981.
    Citations:    
  45. Desai AS, Schaefer KG, Tulsky JA, Mehra MR. Quality of death after left ventricular assist device implantation: More questions than answers. J Heart Lung Transplant. 2019 04; 38(4):382-384. PMID: 30765305.
    Citations:    
  46. Dewan P, Rørth R, Jhund PS, Shen L, Raparelli V, Petrie MC, Abraham WT, Desai AS, Dickstein K, Køber L, Mogensen UM, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, McMurray JJV. Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women. J Am Coll Cardiol. 2019 01 08; 73(1):29-40. PMID: 30621948.
    Citations:    Fields:    
  47. Beldhuis IE, Myhre PL, Claggett B, Damman K, Fang JC, Lewis EF, O'Meara E, Pitt B, Shah SJ, Voors AA, Pfeffer MA, Solomon SD, Desai AS. Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease. JACC Heart Fail. 2019 01; 7(1):25-32. PMID: 30606484.
    Citations:    Fields:    
  48. Dewan P, Jhund PS, Shen L, Petrie MC, Abraham WT, Atif Ali M, Chen CH, Desai AS, Dickstein K, Huang J, Kiatchoosakun S, Kim KS, Køber L, Lai WT, Liao Y, Mogensen UM, Oh BH, Packer M, Rouleau JL, Shi V, Sibulo AS, Solomon SD, Sritara P, Swedberg K, Tsutsui H, Zile MR, McMurray JJV. Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas. Eur J Heart Fail. 2019 May; 21(5):577-587. PMID: 30536678.
    Citations:    Fields:    
  49. Rørth R, Jhund PS, Kristensen SL, Desai AS, Køber L, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJV. The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes. Eur J Heart Fail. 2019 01; 21(1):40-49. PMID: 30537261.
    Citations:    Fields:    
  50. Srivastava PK, Claggett BL, Solomon SD, McMurray JJV, Packer M, Zile MR, Desai AS, Rouleau JL, Swedberg K, Fonarow GC. Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial. JAMA Cardiol. 2018 12 01; 3(12):1226-1231. PMID: 30484837.
    Citations:    Fields:    
  51. Huynh T, Harty BJ, Claggett B, Fleg JL, McKinlay SM, Anand IS, Lewis EF, Joseph J, Desai AS, Sweitzer NK, Pitt B, Pfeffer MA, Rouleau JL. Comparison of Outcomes in Patients With Diabetes Mellitus Treated With Versus Without Insulin?+?Heart Failure With Preserved Left Ventricular Ejection Fraction (from the TOPCAT Study). Am J Cardiol. 2019 02 15; 123(4):611-617. PMID: 30612727.
    Citations:    Fields:    
  52. Vuong JT, Jacob SA, Alexander KM, Singh A, Liao R, Desai AS, Dorbala S. Mortality From Heart Failure and Dementia in the United States: CDC WONDER 1999-2016. J Card Fail. 2019 Feb; 25(2):125-129. PMID: 30471348.
    Citations:    Fields:    
  53. Selvaraj S, Claggett B, Shah SJ, Anand I, Rouleau JL, O'Meara E, Desai AS, Lewis EF, Pitt B, Sweitzer NK, Fang JC, Pfeffer MA, Solomon SD. Prognostic Value of Albuminuria and Influence of Spironolactone in Heart Failure With Preserved Ejection Fraction. Circ Heart Fail. 2018 11; 11(11):e005288. PMID: 30571191.
    Citations:    Fields:    
  54. Myhre PL, O'Meara E, Claggett BL, de Denus S, Jarolim P, Anand IS, Beldhuis IE, Fleg JL, Lewis E, Pitt B, Rouleau JL, Solomon SD, Pfeffer MA, Desai AS. Cardiac Troponin I and Risk of Cardiac Events in Patients With Heart Failure and Preserved Ejection Fraction. Circ Heart Fail. 2018 11; 11(11):e005312. PMID: 30571192.
    Citations:    Fields:    
  55. Myhre PL, Vaduganathan M, Claggett BL, Anand IS, Sweitzer NK, Fang JC, O'Meara E, Shah SJ, Desai AS, Lewis EF, Rouleau J, Pitt B, Pfeffer MA, Solomon SD. Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial. JAMA Cardiol. 2018 10 01; 3(10):1000-1005. PMID: 30140899.
    Citations:    Fields:    
  56. Wagholikar KB, Fischer CM, Goodson A, Herrick CD, Rees M, Toscano E, MacRae CA, Scirica BM, Desai AS, Murphy SN. Extraction of Ejection Fraction from Echocardiography Notes for Constructing a Cohort of Patients having Heart Failure with reduced Ejection Fraction (HFrEF). J Med Syst. 2018 Sep 25; 42(11):209. PMID: 30255347.
    Citations:    Fields:    Translation:Humans
  57. Sanders NA, Supiano MA, Lewis EF, Liu J, Claggett B, Pfeffer MA, Desai AS, Sweitzer NK, Solomon SD, Fang JC. The frailty syndrome and outcomes in the TOPCAT trial. Eur J Heart Fail. 2018 11; 20(11):1570-1577. PMID: 30225878.
    Citations:    Fields:    
  58. Gilstrap LG, Stevenson LW, Small R, Parambi R, Hamershock R, Greenberg J, Carr C, Ghazinouri R, Rathman L, Han E, Mehra MR, Desai AS. Reasons for Guideline Nonadherence at Heart Failure Discharge. J Am Heart Assoc. 2018 08 07; 7(15):e008789. PMID: 30371240.
    Citations:    Fields:    
  59. De Feria AE, Bajaj NS, Polk DM, Desai AS, Blankstein R, Vaduganathan M. Pectus Excavatum and Right Ventricular Compression in a Young Athlete with Syncope. Am J Med. 2018 11; 131(11):e451-e453. PMID: 30076820.
    Citations:    Fields:    
  60. Cikes M, Claggett B, Shah AM, Desai AS, Lewis EF, Shah SJ, Anand IS, O'Meara E, Rouleau JL, Sweitzer NK, Fang JC, Saksena S, Pitt B, Pfeffer MA, Solomon SD. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial. JACC Heart Fail. 2018 08; 6(8):689-697. PMID: 30007557.
    Citations: 1     Fields:    
  61. Chandra A, Lewis EF, Claggett BL, Desai AS, Packer M, Zile MR, Swedberg K, Rouleau JL, Shi VC, Lefkowitz MP, Katova T, McMurray JJV, Solomon SD. Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure: A Secondary Analysis of the PARADIGM-HF Trial. JAMA Cardiol. 2018 06 01; 3(6):498-505. PMID: 29617523.
    Citations: 2     Fields:    
  62. O'Donnell AE, Schaefer KG, Stevenson LW, DeVoe K, Walsh K, Mehra MR, Desai AS. Social Worker-Aided Palliative Care Intervention in High-risk Patients With Heart Failure (SWAP-HF): A Pilot Randomized Clinical Trial. JAMA Cardiol. 2018 06 01; 3(6):516-519. PMID: 29641819.
    Citations:    Fields:    
  63. Buckley LF, Cooper IM, Navarro-Velez K, Shea EL, Joly JM, Mehra MR, Stevenson LW, Desai AS. Burden of nursing activities during hemodynamic monitoring of heart failure patients. Heart Lung. 2018 Jul - Aug; 47(4):304-307. PMID: 29801671.
    Citations:    Fields:    
  64. Luk A, Groarke JD, Desai AS, Mahmood SS, Gopal DM, Joyce E, Shah SP, Lindenfeld J, Stevenson L, Lakdawala NK. First spot urine sodium after initial diuretic identifies patients at high risk for adverse outcome after heart failure hospitalization. Am Heart J. 2018 09; 203:95-100. PMID: 29907406.
    Citations:    Fields:    
  65. Joly JM, Desai AS. Sacubitril/Valsartan: From Clinical Trials to Real-world Experience. Curr Treat Options Cardiovasc Med. 2018 Apr 23; 20(6):45. PMID: 29687191.
    Citations:    
  66. Damman K, Gori M, Claggett B, Jhund PS, Senni M, Lefkowitz MP, Prescott MF, Shi VC, Rouleau JL, Swedberg K, Zile MR, Packer M, Desai AS, Solomon SD, McMurray JJV. Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure. JACC Heart Fail. 2018 06; 6(6):489-498. PMID: 29655829.
    Citations: 1     Fields:    
  67. Vardeny O, Claggett B, Kachadourian J, Pearson SM, Desai AS, Packer M, Rouleau J, Zile MR, Swedberg K, Lefkowitz M, Shi V, McMurray JJV, Solomon SD. Incidence, Predictors, and Outcomes Associated With Hypotensive Episodes Among Heart Failure Patients Receiving Sacubitril/Valsartan or Enalapril: The PARADIGM-HF Trial (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure). Circ Heart Fail. 2018 04; 11(4):e004745. PMID: 29643067.
    Citations:    Fields:    
  68. Desai AS, Liu J, Pfeffer MA, Claggett B, Fleg J, Lewis EF, McKinlay S, O'Meara E, Shah SJ, Sweitzer NK, Solomon S, Pitt B. Incident Hyperkalemia, Hypokalemia, and Clinical Outcomes During Spironolactone Treatment of Heart Failure With Preserved Ejection Fraction: Analysis of the TOPCAT Trial. J Card Fail. 2018 May; 24(5):313-320. PMID: 29572190.
    Citations:    Fields:    
  69. Taqueti VR, Solomon SD, Shah AM, Desai AS, Groarke JD, Osborne MT, Hainer J, Bibbo CF, Dorbala S, Blankstein R, Di Carli MF. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J. 2018 03 07; 39(10):840-849. PMID: 29293969.
    Citations: 5     Fields:    
  70. Hicks KA, Mahaffey KW, Mehran R, Nissen SE, Wiviott SD, Dunn B, Solomon SD, Marler JR, Teerlink JR, Farb A, Morrow DA, Targum SL, Sila CA, Thanh Hai MT, Jaff MR, Joffe HV, Cutlip DE, Desai AS, Lewis EF, Gibson CM, Landray MJ, Lincoff AM, White CJ, Brooks SS, Rosenfield K, Domanski MJ, Lansky AJ, McMurray JJV, Tcheng JE, Steinhubl SR, Burton P, Mauri L, O'Connor CM, Pfeffer MA, Hung HMJ, Stockbridge NL, Chaitman BR, Temple RJ. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. J Am Coll Cardiol. 2018 03 06; 71(9):1021-1034. PMID: 29495982.
    Citations: 1     Fields:    
  71. Vaduganathan M, Claggett BL, Chatterjee NA, Anand IS, Sweitzer NK, Fang JC, O'Meara E, Shah SJ, Hegde SM, Desai AS, Lewis EF, Rouleau J, Pitt B, Pfeffer MA, Solomon SD. Sudden Death in Heart Failure With Preserved Ejection Fraction: A Competing Risks Analysis From the TOPCAT Trial. JACC Heart Fail. 2018 08; 6(8):653-661. PMID: 29501806.
    Citations: 2     Fields:    
  72. Lewis EF, Claggett B, Shah AM, Liu J, Shah SJ, Anand I, O'Meara E, Sweitzer NK, Rouleau JL, Fang JC, Desai AS, Retta TM, Solomon SD, Heitner JF, Stamos TD, Boineau R, Pitt B, Pfeffer MA. Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial. Circ Heart Fail. 2018 03; 11(3):e004457. PMID: 29664406.
    Citations:    Fields:    
  73. Hicks KA, Mahaffey KW, Mehran R, Nissen SE, Wiviott SD, Dunn B, Solomon SD, Marler JR, Teerlink JR, Farb A, Morrow DA, Targum SL, Sila CA, Hai MTT, Jaff MR, Joffe HV, Cutlip DE, Desai AS, Lewis EF, Gibson CM, Landray MJ, Lincoff AM, White CJ, Brooks SS, Rosenfield K, Domanski MJ, Lansky AJ, McMurray JJV, Tcheng JE, Steinhubl SR, Burton P, Mauri L, O'Connor CM, Pfeffer MA, Hung HMJ, Stockbridge NL, Chaitman BR, Temple RJ. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. Circulation. 2018 02 27; 137(9):961-972. PMID: 29483172.
    Citations:    Fields:    
  74. Mogensen UM, Gong J, Jhund PS, Shen L, Køber L, Desai AS, Lefkowitz MP, Packer M, Rouleau JL, Solomon SD, Claggett BL, Swedberg K, Zile MR, Mueller-Velten G, McMurray JJV. Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF). Eur J Heart Fail. 2018 04; 20(4):760-768. PMID: 29431251.
    Citations:    Fields:    Translation:Humans
  75. Brinkley DM, Burpee LJ, Chaudhry SP, Smallwood JA, Lindenfeld J, Lakdawala NK, Desai AS, Stevenson LW. Spot Urine Sodium as Triage for Effective Diuretic Infusion in an Ambulatory Heart Failure Unit. J Card Fail. 2018 06; 24(6):349-354. PMID: 29410227.
    Citations:    Fields:    
  76. Bravo PE, Bergmark BA, Vita T, Taqueti VR, Gupta A, Seidelmann S, Christensen TE, Osborne MT, Shah NR, Ghosh N, Hainer J, Bibbo CF, Harrington M, Costantino F, Mehra MR, Dorbala S, Blankstein R, Desai A, Stevenson L, Givertz MM, Di Carli MF. Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy. Eur Heart J. 2018 01 21; 39(4):316-323. PMID: 29236988.
    Citations: 1     Fields:    
  77. Kelly NP, Gerhard-Herman M, Desai AS, Miller AL, Loscalzo J. An Unusual Cause of Leg Pain. N Engl J Med. 2017 12 07; 377(23):2267-2272. PMID: 29211675.
    Citations:    Fields:    Translation:Humans
  78. Thorvaldsen T, Claggett BL, Shah A, Cheng S, Agarwal SK, Wruck LM, Chang PP, Rosamond WD, Lewis EF, Desai AS, Lund LH, Solomon SD. Predicting Risk in Patients Hospitalized for Acute Decompensated Heart Failure and Preserved Ejection Fraction: The Atherosclerosis Risk in Communities Study Heart Failure Community Surveillance. Circ Heart Fail. 2017 Dec; 10(12). PMID: 29242352.
    Citations:    Fields:    Translation:HumansPHPublic Health
  79. Mogensen UM, Køber L, Jhund PS, Desai AS, Senni M, Kristensen SL, Dukát A, Chen CH, Ramires F, Lefkowitz MP, Prescott MF, Shi VC, Rouleau JL, Solomon SD, Swedberg K, Packer M, McMurray JJV. Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM-HF. Eur J Heart Fail. 2018 03; 20(3):514-522. PMID: 29193563.
    Citations:    Fields:    Translation:Humans
  80. Kelly NP, Vaidya A, Gerhard-Herman M, Desai AS. An Unusual Cause of Leg Pain. N Engl J Med. 2017 Nov 16; 377(20):e29. PMID: 29141172.
    Citations:    Fields:    Translation:Humans
  81. Selvaraj S, Claggett B, Shah SJ, Anand I, Rouleau JL, Desai AS, Lewis EF, Pitt B, Sweitzer NK, Pfeffer MA, Solomon SD. Systolic blood pressure and cardiovascular outcomes in heart failure with preserved ejection fraction: an analysis of the TOPCAT trial. Eur J Heart Fail. 2018 03; 20(3):483-490. PMID: 29148144.
    Citations: 1     Fields:    Translation:Humans
  82. Mogensen UM, Jhund PS, Abraham WT, Desai AS, Dickstein K, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Køber L, McMurray JJV. Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction. J Am Coll Cardiol. 2017 Nov 14; 70(20):2490-2500. PMID: 29145948.
    Citations: 4     Fields:    Translation:Humans
  83. Seferovic JP, Pfeffer MA, Claggett B, Desai AS, de Zeeuw D, Haffner SM, McMurray JJV, Parving HH, Solomon SD, Chaturvedi N. Three-question set from Michigan Neuropathy Screening Instrument adds independent prognostic information on cardiovascular outcomes: analysis of ALTITUDE trial. Diabetologia. 2018 03; 61(3):581-588. PMID: 29098323.
    Citations:    Fields:    Translation:Humans
  84. Bajaj NS, Claggett B, Lewis EF, Desai AS, Fang JC, O'Meara E, Shah SJ, Sweitzer NK, Fleg JL, Pitt B, Rouleau JL, Finn P, Pfeffer MA, Solomon SD. Influence of ejection fraction on cause-specific mortality in heart failure with preserved ejection fraction. Eur J Heart Fail. 2018 04; 20(4):815-816. PMID: 29067754.
    Citations: 1     Fields:    Translation:Humans
  85. Kristensen SL, Jhund PS, Mogensen UM, Rørth R, Abraham WT, Desai A, Dickstein K, Rouleau JL, Zile MR, Swedberg K, Packer M, Solomon SD, Køber L, McMurray JJV. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation. Circ Heart Fail. 2017 Oct; 10(10). PMID: 29018174.
    Citations: 2     Fields:    Translation:Humans
  86. Welsh P, Kou L, Yu C, Anand I, van Veldhuisen DJ, Maggioni AP, Desai AS, Solomon SD, Pfeffer MA, Cheng S, Gullestad L, Aukrust P, Ueland T, Swedberg K, Young JB, Kattan MW, Sattar N, McMurray JJV. Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study. Eur J Heart Fail. 2018 02; 20(2):268-277. PMID: 28960777.
    Citations:    Fields:    Translation:Humans
  87. Desai AS, Pfeffer MA. Beyond the P-value and the sound bite: learning from 'negative' clinical trials. Eur Heart J. 2017 08 07; 38(30):2349-2351. PMID: 28810671.
    Citations:    Fields:    
  88. Lewis EF, Claggett BL, McMurray JJV, Packer M, Lefkowitz MP, Rouleau JL, Liu J, Shi VC, Zile MR, Desai AS, Solomon SD, Swedberg K. Health-Related Quality of Life Outcomes in PARADIGM-HF. Circ Heart Fail. 2017 Aug; 10(8). PMID: 28784687.
    Citations:    Fields:    Translation:Humans
  89. DeFilippis EM, Desai AS. Treatment of Hyperkalemia in Heart Failure. Curr Heart Fail Rep. 2017 08; 14(4):266-274. PMID: 28656517.
    Citations: 2     Fields:    Translation:Humans
  90. Solomon SD, Desai AS. Acute Heart Failure: One Syndrome or Many? J Am Coll Cardiol. 2017 06 27; 69(25):3040-3041. PMID: 28641793.
    Citations: 1     Fields:    
  91. Solomon SD, Rizkala AR, Gong J, Wang W, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, Van Veldhuisen DJ, Zannad F, Zile MR, Desai AS, Shi VC, Lefkowitz MP, McMurray JJV. Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial. JACC Heart Fail. 2017 07; 5(7):471-482. PMID: 28662936.
    Citations: 6     Fields:    Translation:Humans
  92. Barghash MH, Desai AS. First-in-Class Composite Angiotensin Receptor-Neprilysin Inhibitors (ARNI) in Practice. Clin Pharmacol Ther. 2017 Aug; 102(2):265-268. PMID: 28512738.
    Citations:    Fields:    Translation:HumansAnimals
  93. Desai AS, Jarcho JA. Levosimendan for the Low Cardiac Output Syndrome after Cardiac Surgery. N Engl J Med. 2017 05 25; 376(21):2076-2078. PMID: 28538112.
    Citations: 1     Fields:    Translation:Humans
  94. de Denus S, O'Meara E, Desai AS, Claggett B, Lewis EF, Leclair G, Jutras M, Lavoie J, Solomon SD, Pitt B, Pfeffer MA, Rouleau JL. Spironolactone Metabolites in TOPCAT - New Insights into Regional Variation. N Engl J Med. 2017 04 27; 376(17):1690-1692. PMID: 28445660.
    Citations: 12     Fields:    Translation:Humans
  95. Anand IS, Claggett B, Liu J, Shah AM, Rector TS, Shah SJ, Desai AS, O'Meara E, Fleg JL, Pfeffer MA, Pitt B, Solomon SD. Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial. JACC Heart Fail. 2017 04; 5(4):241-252. PMID: 28359411.
    Citations: 9     Fields:    Translation:Humans
  96. Desai AS, Bhimaraj A, Bharmi R, Jermyn R, Bhatt K, Shavelle D, Redfield MM, Hull R, Pelzel J, Davis K, Dalal N, Adamson PB, Heywood JT. Ambulatory Hemodynamic Monitoring Reduces Heart Failure Hospitalizations in "Real-World" Clinical Practice. J Am Coll Cardiol. 2017 May 16; 69(19):2357-2365. PMID: 28330751.
    Citations: 12     Fields:    Translation:Humans
  97. Seferovic JP, Claggett B, Seidelmann SB, Seely EW, Packer M, Zile MR, Rouleau JL, Swedberg K, Lefkowitz M, Shi VC, Desai AS, McMurray JJV, Solomon SD. Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial. Lancet Diabetes Endocrinol. 2017 05; 5(5):333-340. PMID: 28330649.
    Citations: 12     Fields:    Translation:Humans
  98. Ho CY, McMurray JJV, Cirino AL, Colan SD, Day SM, Desai AS, Lipshultz SE, MacRae CA, Shi L, Solomon SD, Orav EJ, Braunwald E. The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial. Am Heart J. 2017 May; 187:145-155. PMID: 28454798.
    Citations: 3     Fields:    Translation:HumansCellsCTClinical Trials
  99. Gilstrap LG, Fonarow GC, Desai AS, Liang L, Matsouaka R, DeVore AD, Smith EE, Heidenreich P, Hernandez AF, Yancy CW, Bhatt DL. Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction. J Am Heart Assoc. 2017 02 11; 6(2). PMID: 28189999.
    Citations: 4     Fields:    Translation:Humans
  100. Sands SA, Mebrate Y, Edwards BA, Nemati S, Manisty CH, Desai AS, Wellman A, Willson K, Francis DP, Butler JP, Malhotra A. Resonance as the Mechanism of Daytime Periodic Breathing in Patients with Heart Failure. Am J Respir Crit Care Med. 2017 01 15; 195(2):237-246. PMID: 27559818.
    Citations: 3     Fields:    Translation:Humans
  101. Ibrahim NE, Desai AS, Singh JP, Januzzi JL. Advances in Heart Failure Management: Improving Outcomes With Innovation. Rev Cardiovasc Med. 2017; 18(S1):S1-S16. PMID: 28233764.
    Citations:    Fields:    
  102. Desai AS, Vardeny O, Claggett B, McMurray JJ, Packer M, Swedberg K, Rouleau JL, Zile MR, Lefkowitz M, Shi V, Solomon SD. Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril: A Secondary Analysis of the PARADIGM-HF Trial. JAMA Cardiol. 2017 01 01; 2(1):79-85. PMID: 27842179.
    Citations: 10     Fields:    
  103. Zile MR, Claggett BL, Prescott MF, McMurray JJ, Packer M, Rouleau JL, Swedberg K, Desai AS, Gong J, Shi VC, Solomon SD. Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure. J Am Coll Cardiol. 2016 Dec 06; 68(22):2425-2436. PMID: 27908347.
    Citations: 5     Fields:    Translation:Humans
  104. Nadruz W, Claggett BL, McMurray JJ, Packer M, Zile MR, Rouleau JL, Desai AS, Swedberg K, Lefkowitz M, Shi VC, Prescott MF, Solomon SD. Impact of Body Mass Index on the Accuracy of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide for Predicting Outcomes in Patients With Chronic Heart Failure and Reduced Ejection Fraction: Insights From the PARADIGM-HF Study (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial). Circulation. 2016 11 29; 134(22):1785-1787. PMID: 27895026.
    Citations: 2     Fields:    Translation:Humans
  105. Vaduganathan M, Desai AS. Angiotensin-Neprilysin Inhibition as a Paradigm for All? Curr Cardiol Rep. 2016 11; 18(11):115. PMID: 27747488.
    Citations: 2     Fields:    Translation:Humans
  106. Buckley LF, Seoane-Vazquez E, Cheng JW, Aldemerdash A, Cooper IM, Matta L, Medina DS, Mehra MR, Navarro-Velez K, Shea EL, Weintraub JR, Stevenson LW, Desai AS. Comparison of Ambulatory, High-Dose, Intravenous Diuretic Therapy to Standard Hospitalization and Diuretic Therapy for Treatment of Acute Decompensated Heart Failure. Am J Cardiol. 2016 Nov 01; 118(9):1350-1355. PMID: 27772698.
    Citations:    Fields:    Translation:Humans
  107. Desai AS, Claggett BL, Packer M, Zile MR, Rouleau JL, Swedberg K, Shi V, Lefkowitz M, Starling R, Teerlink J, McMurray JJV, Solomon SD. Influence of Sacubitril/Valsartan (LCZ696) on 30-Day Readmission After Heart Failure Hospitalization. J Am Coll Cardiol. 2016 07 19; 68(3):241-248. PMID: 27417000.
    Citations: 5     Fields:    Translation:Humans
  108. Solomon SD, Claggett B, Packer M, Desai A, Zile MR, Swedberg K, Rouleau J, Shi V, Lefkowitz M, McMurray JJV. Efficacy of Sacubitril/Valsartan Relative to a Prior Decompensation: The PARADIGM-HF Trial. JACC Heart Fail. 2016 10; 4(10):816-822. PMID: 27395349.
    Citations: 3     Fields:    Translation:Humans
  109. Vardeny O, Claggett B, Packer M, Zile MR, Rouleau J, Swedberg K, Teerlink JR, Desai AS, Lefkowitz M, Shi V, McMurray JJ, Solomon SD. Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial. Eur J Heart Fail. 2016 Oct; 18(10):1228-1234. PMID: 27283779.
    Citations: 9     Fields:    Translation:Humans
  110. Adamson PB, Abraham WT, Stevenson LW, Desai AS, Lindenfeld J, Bourge RC, Bauman J. Pulmonary Artery Pressure-Guided Heart Failure Management Reduces 30-Day Readmissions. Circ Heart Fail. 2016 06; 9(6). PMID: 27220593.
    Citations: 8     Fields:    Translation:Humans
  111. Desai AS, Solomon S, Claggett B, McMurray JJ, Rouleau J, Swedberg K, Zile M, Lefkowitz M, Shi V, Packer M. Factors Associated With Noncompletion During the Run-In Period Before Randomization and Influence on the Estimated Benefit of LCZ696 in the PARADIGM-HF Trial. Circ Heart Fail. 2016 06; 9(6). PMID: 27296397.
    Citations: 2     Fields:    Translation:Humans
  112. Desai AS. Intensive Management to Reduce Hospitalizations in Patients With Heart Failure. Circulation. 2016 Apr 26; 133(17):1704-7. PMID: 27143153.
    Citations: 2     Fields:    Translation:Humans
  113. Sabe MA, Claggett B, Burdmann EA, Desai AS, Ivanovich P, Kewalramani R, Lewis EF, McMurray JJ, Olson KA, Parfrey P, Solomon SD, Pfeffer MA. Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). J Am Heart Assoc. 2016 04 23; 5(4). PMID: 27108247.
    Citations: 2     Fields:    Translation:Humans
  114. Desai AS, Jhund PS. After TOPCAT: What to do now in Heart Failure with Preserved Ejection Fraction. Eur Heart J. 2016 Nov 01; 37(41):3135-3140. PMID: 27075872.
    Citations:    
  115. Dempsey JT, Matta LS, Carter DM, Stevens CA, Stevenson LW, Desai AS, Cheng JW. Assessment of Drug Therapy-Related Issues in an Outpatient Heart Failure Population and the Potential Impact of Pharmacist-Driven Intervention. J Pharm Pract. 2017 Jun; 30(3):318-323. PMID: 27080398.
    Citations: 3     Fields:    Translation:Humans
  116. Patel AN, Henry TD, Quyyumi AA, Schaer GL, Anderson RD, Toma C, East C, Remmers AE, Goodrich J, Desai AS, Recker D, DeMaria A. Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial. Lancet. 2016 Jun 11; 387(10036):2412-21. PMID: 27059887.
    Citations: 12     Fields:    Translation:Humans
  117. McMurray JJ, Krum H, Abraham WT, Dickstein K, Køber LV, Desai AS, Solomon SD, Greenlaw N, Ali MA, Chiang Y, Shao Q, Tarnesby G, Massie BM. Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure. N Engl J Med. 2016 Apr 21; 374(16):1521-32. PMID: 27043774.
    Citations: 28     Fields:    Translation:Humans
  118. Joseph J, Claggett BC, Anand IS, Fleg JL, Huynh T, Desai AS, Solomon SD, O'Meara E, Mckinlay S, Pitt B, Pfeffer MA, Lewis EF. QRS Duration Is a Predictor of Adverse Outcomes in Heart Failure With Preserved Ejection Fraction. JACC Heart Fail. 2016 06; 4(6):477-86. PMID: 27039126.
    Citations: 2     Fields:    Translation:Humans
  119. Solomon SD, Claggett B, Desai AS, Packer M, Zile M, Swedberg K, Rouleau JL, Shi VC, Starling RC, Kozan Ö, Dukat A, Lefkowitz MP, McMurray JJ. Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial. Circ Heart Fail. 2016 Mar; 9(3):e002744. PMID: 26915374.
    Citations: 13     Fields:    Translation:Humans
  120. Lewis EF, Kim HY, Claggett B, Spertus J, Heitner JF, Assmann SF, Kenwood CT, Solomon SD, Desai AS, Fang JC, McKinlay SA, Pitt BA, Pfeffer MA. Impact of Spironolactone on Longitudinal Changes in Health-Related Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial. Circ Heart Fail. 2016 Mar; 9(3):e001937. PMID: 26962133.
    Citations: 7     Fields:    Translation:Humans
  121. Joyce E, Chung C, Badloe S, Odutayo K, Desai A, Givertz MM, Nohria A, Lakdawala NK, Stewart GC, Young M, Weintraub J, Stevenson LW, Lewis EF. Variable Contribution of Heart Failure to Quality of Life in Ambulatory Heart Failure With Reduced, Better, or Preserved Ejection Fraction. JACC Heart Fail. 2016 Mar; 4(3):184-93. PMID: 26874379.
    Citations: 3     Fields:    Translation:Humans
  122. Costanzo MR, Stevenson LW, Adamson PB, Desai AS, Heywood JT, Bourge RC, Bauman J, Abraham WT. Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring. JACC Heart Fail. 2016 05; 4(5):333-44. PMID: 26874388.
    Citations: 13     Fields:    Translation:Humans
  123. Greenberg B, Butler J, Felker GM, Ponikowski P, Voors AA, Desai AS, Barnard D, Bouchard A, Jaski B, Lyon AR, Pogoda JM, Rudy JJ, Zsebo KM. Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial. Lancet. 2016 Mar 19; 387(10024):1178-86. PMID: 26803443.
    Citations: 41     Fields:    Translation:HumansCellsCTClinical Trials
  124. Weinrauch LA, D'Elia JA, Finn P, Lewis EF, Desai AS, Claggett BL, Cooper ME, McGill JB. Strategies for glucose control in a study population with diabetes, renal disease and anemia (Treat study). Diabetes Res Clin Pract. 2016 Mar; 113:143-51. PMID: 26830074.
    Citations: 2     Fields:    Translation:Humans
  125. Heerspink HJ, Persson F, Brenner BM, Chaturvedi N, Brunel P, McMurray JJ, Desai AS, Solomon SD, Pfeffer MA, Parving HH, de Zeeuw D. Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial. Lancet Diabetes Endocrinol. 2016 Apr; 4(4):309-17. PMID: 26774608.
    Citations: 4     Fields:    Translation:Humans
  126. Heerspink HJ, Ninomiya T, Persson F, Brenner BM, Brunel P, Chaturvedi N, Desai AS, Haffner SM, Mcmurray JJ, Solomon SD, Pfeffer MA, Parving HH, de Zeeuw D. Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trial. Diabetes Obes Metab. 2016 Feb; 18(2):169-77. PMID: 26511599.
    Citations: 7     Fields:    Translation:Humans
  127. Kristensen SL, Preiss D, Jhund PS, Squire I, Cardoso JS, Merkely B, Martinez F, Starling RC, Desai AS, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, McMurray JJ, Packer M. Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial. Circ Heart Fail. 2016 Jan; 9(1). PMID: 26754626.
    Citations: 22     Fields:    Translation:Humans
  128. Vardeny O, Claggett B, Udell JA, Packer M, Zile M, Rouleau J, Swedberg K, Desai AS, Lefkowitz M, Shi V, McMurray JJV, Solomon SD. Influenza Vaccination in Patients With Chronic Heart Failure: The PARADIGM-HF Trial. JACC Heart Fail. 2016 Feb; 4(2):152-158. PMID: 26746371.
    Citations: 10     Fields:    Translation:HumansCellsPHPublic Health
  129. Buckley LF, Carter DM, Matta L, Cheng JW, Stevens C, Belenkiy RM, Burpee LJ, Young MA, Weiffenbach CS, Smallwood JA, Stevenson LW, Desai AS. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit. JACC Heart Fail. 2016 Jan; 4(1):1-8. PMID: 26656139.
    Citations: 2     Fields:    Translation:Humans
  130. Desai AS. Implantable Hemodynamic Monitoring in Ambulatory Heart Failure: Who, When, Why, How? Curr Cardiol Rep. 2015 Dec; 17(12):113. PMID: 26482756.
    Citations:    Fields:    Translation:Humans
  131. Simpson J, Jhund PS, Silva Cardoso J, Martinez F, Mosterd A, Ramires F, Rizkala AR, Senni M, Squire I, Gong J, Lefkowitz MP, Shi VC, Desai AS, Rouleau JL, Swedberg K, Zile MR, McMurray JJV, Packer M, Solomon SD. Comparing LCZ696 with enalapril according to baseline risk using the MAGGIC and EMPHASIS-HF risk scores: an analysis of mortality and morbidity in PARADIGM-HF. J Am Coll Cardiol. 2015 Nov 10; 66(19):2059-2071. PMID: 26541915.
    Citations: 11     Fields:    Translation:Humans
  132. Krum H, McMurray JJ, Abraham WT, Dickstein K, Køber L, Desai AS, Solomon SD, Chiang Y, Gimpelewicz C, Reimund B, Ali MA, Tarnesby G, Massie BM. The Aliskiren Trial to Minimize OutcomeS in Patients with HEart failure trial (ATMOSPHERE): revised statistical analysis plan and baseline characteristics. Eur J Heart Fail. 2015 Oct; 17(10):1075-83. PMID: 26511146.
    Citations: 4     Fields:    Translation:Humans
  133. Bello NA, Lewis EF, Desai AS, Anand IS, Krum H, McMurray JJ, Olson K, Solomon SD, Swedberg K, van Veldhuisen DJ, Young JB, Pfeffer MA. Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney disease. Eur J Heart Fail. 2015 Nov; 17(11):1201-7. PMID: 26423928.
    Citations: 3     Fields:    Translation:Humans
  134. Zipes DP, Calkins H, Daubert JP, Ellenbogen KA, Field ME, Fisher JD, Fogel RI, Frankel DS, Gupta A, Indik JH, Kusumoto FM, Lindsay BD, Marine JE, Mehta LS, Mendes LA, Miller JM, Munger TM, Sauer WH, Shen WK, Stevenson WG, Su WW, Tracy CM, Tsiperfal A, Williams ES, Halperin JL, Arrighi JA, Awtry EH, Bates ER, Brush JE, Costa S, Daniels L, Desai A, Drachman DE, Fernandes S, Freeman R, Ijioma N, Khan SS, Kuvin JT, Marine JE, McPherson JA, Mendes LA, Sivaram CA, Spicer RL, Wang A, Weitz HH. 2015 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac Electrophysiology (A Revision of the ACC/AHA 2006 Update of the Clinical Competence Statement on Invasive Electrophysiology Studies, Catheter Ablation, and Cardioversion). Circ Arrhythm Electrophysiol. 2015 Dec; 8(6):1522-51. PMID: 26386016.
    Citations:    Fields:    Translation:Humans
  135. Solomon SD, Claggett B, Lewis EF, Desai A, Anand I, Sweitzer NK, O'Meara E, Shah SJ, McKinlay S, Fleg JL, Sopko G, Pitt B, Pfeffer MA. Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction. Eur Heart J. 2016 Feb 01; 37(5):455-62. PMID: 26374849.
    Citations: 19     Fields:    Translation:Humans
  136. Jhund PS, Fu M, Bayram E, Chen CH, Negrusz-Kawecka M, Rosenthal A, Desai AS, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, McMurray JJ, Packer M. Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF. Eur Heart J. 2015 Oct 07; 36(38):2576-84. PMID: 26231885.
    Citations: 24     Fields:    Translation:Humans
  137. Jhund PS, McMurray JJ, Chaturvedi N, Brunel P, Desai AS, Finn PV, Haffner SM, Solomon SD, Weinrauch LA, Claggett BL, Pfeffer MA. Mortality following a cardiovascular or renal event in patients with type 2 diabetes in the ALTITUDE trial. Eur Heart J. 2015 Sep 21; 36(36):2463-9. PMID: 26188211.
    Citations: 3     Fields:    Translation:Humans
  138. Nohria A, Desai AS. Reducing Readmissions With Novel Cardiac Resynchronization Therapy Programming: Is Meeting the 30-Day Metric Enough? JACC Heart Fail. 2015 Jul; 3(7):573-575. PMID: 26071615.
    Citations:    Fields:    Translation:Humans
  139. Desai AS, McMurray JJ, Packer M, Swedberg K, Rouleau JL, Chen F, Gong J, Rizkala AR, Brahimi A, Claggett B, Finn PV, Hartley LH, Liu J, Lefkowitz M, Shi V, Zile MR, Solomon SD. Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients. Eur Heart J. 2015 Aug 07; 36(30):1990-7. PMID: 26022006.
    Citations: 34     Fields:    Translation:Humans
  140. Charytan DM, Lewis EF, Desai AS, Weinrauch LA, Ivanovich P, Toto RD, Claggett B, Liu J, Hartley LH, Finn P, Singh AK, Levey AS, Pfeffer MA, McMurray JJ, Solomon SD. Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). Am J Kidney Dis. 2015 Sep; 66(3):429-40. PMID: 25935581.
    Citations: 1     Fields:    Translation:Humans
  141. McMurray J, Packer M, Desai A, Gong J, Greenlaw N, Lefkowitz M, Rizkala A, Shi V, Rouleau J, Solomon S, Swedberg K, Zile MR, Andersen K, Arango JL, Arnold M, Belohlávek J, Böhm M, Boytsov S, Burgess L, Cabrera W, Chen CH, Erglis A, Fu M, Gomez E, Gonzalez A, Hagege AA, Katova T, Kiatchoosakun S, Kim KS, Bayram E, Martinez F, Merkely B, Mendoza I, Mosterd A, Negrusz-Kawecka M, Peuhkurinen K, Ramires F, Refsgaard J, Senni M, Sibulo AS, Silva-Cardoso J, Squire I, Starling RC, Vinereanu D, Teerlink JR, Wong R. A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure. Eur Heart J. 2015 Feb 14; 36(7):434-9. PMID: 25416329.
    Citations: 12     Fields:    Translation:Humans
  142. Cheng S, Shah AM, Albisu JP, Desai AS, Hilkert RJ, Izzo J, Oparil S, Pitt B, Solomon SD. Reversibility of left ventricular mechanical dysfunction in patients with hypertensive heart disease. J Hypertens. 2014 Dec; 32(12):2479-86; discussion 2486-7. PMID: 25232755.
    Citations: 1     Fields:    Translation:Humans
  143. Pfeffer MA, Claggett B, Assmann SF, Boineau R, Anand IS, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Heitner JF, Lewis EF, O'Meara E, Rouleau JL, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, McKinlay SM, Pitt B. Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial. Circulation. 2015 Jan 06; 131(1):34-42. PMID: 25406305.
    Citations: 82     Fields:    Translation:Humans
  144. Packer M, McMurray JJ, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile M, Andersen K, Arango JL, Arnold JM, Belohlávek J, Böhm M, Boytsov S, Burgess LJ, Cabrera W, Calvo C, Chen CH, Dukat A, Duarte YC, Erglis A, Fu M, Gomez E, Gonzàlez-Medina A, Hagège AA, Huang J, Katova T, Kiatchoosakun S, Kim KS, Kozan Ö, Llamas EB, Martinez F, Merkely B, Mendoza I, Mosterd A, Negrusz-Kawecka M, Peuhkurinen K, Ramires FJ, Refsgaard J, Rosenthal A, Senni M, Sibulo AS, Silva-Cardoso J, Squire IB, Starling RC, Teerlink JR, Vanhaecke J, Vinereanu D, Wong RC. Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure. Circulation. 2015 Jan 06; 131(1):54-61. PMID: 25403646.
    Citations: 79     Fields:    Translation:Humans
  145. Desai AS, Claggett B, Pfeffer MA, Bello N, Finn PV, Granger CB, McMurray JJ, Pocock S, Swedberg K, Yusuf S, Solomon SD. Influence of hospitalization for cardiovascular versus noncardiovascular reasons on subsequent mortality in patients with chronic heart failure across the spectrum of ejection fraction. Circ Heart Fail. 2014 Nov; 7(6):895-902. PMID: 25326006.
    Citations: 3     Fields:    Translation:Humans
  146. Sottile PD, Moss M, Patel JJ, Truwit JD, Sheikh M, Zimmerman JL, Diwakar A, Schmidt GA, Means GT, Katz JN, Desai AS, MacIntyre NR, Poston JT. ATS Core Curriculum 2014: Part II. Adult critical care medicine. Ann Am Thorac Soc. 2014 Oct; 11(8):1307-15. PMID: 25343197.
    Citations:    Fields:    Translation:Humans
  147. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014 Sep 11; 371(11):993-1004. PMID: 25176015.
    Citations: 362     Fields:    Translation:Humans
  148. Shah AM, Claggett B, Sweitzer NK, Shah SJ, Anand IS, O'Meara E, Desai AS, Heitner JF, Li G, Fang J, Rouleau J, Zile MR, Markov V, Ryabov V, Reis G, Assmann SF, McKinlay SM, Pitt B, Pfeffer MA, Solomon SD. Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial. Circ Heart Fail. 2014 Sep; 7(5):740-51. PMID: 25122186.
    Citations: 23     Fields:    Translation:Humans
  149. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz M, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR. Baseline characteristics and treatment of patients in prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF). Eur J Heart Fail. 2014 Jul; 16(7):817-25. PMID: 24828035.
    Citations: 25     Fields:    Translation:Humans
  150. Bello NA, Claggett B, Desai AS, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, Solomon SD. Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction. Circ Heart Fail. 2014 Jul; 7(4):590-5. PMID: 24874200.
    Citations: 10     Fields:    Translation:Humans
  151. Vardeny O, Claggett B, Anand I, Rossignol P, Desai AS, Zannad F, Pitt B, Solomon SD. Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist. Circ Heart Fail. 2014 Jul; 7(4):573-9. PMID: 24812304.
    Citations: 14     Fields:    
  152. Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Harty B, Heitner JF, Kenwood CT, Lewis EF, O'Meara E, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, Yang S, McKinlay SM. Spironolactone for heart failure with preserved ejection fraction. N Engl J Med. 2014 Apr 10; 370(15):1383-92. PMID: 24716680.
    Citations: 211     Fields:    Translation:Humans
  153. Lala A, Desai AS. The role of coronary artery disease in heart failure. Heart Fail Clin. 2014 Apr; 10(2):353-65. PMID: 24656111.
    Citations: 5     Fields:    Translation:Humans
  154. Cheng S, Lam C, Shah A, Claggett B, Desai A, Hilkert RJ, Izzo J, Oparil S, Pitt B, Solomon SD. Age and the effectiveness of anti-hypertensive therapy on improvement in diastolic function. J Hypertens. 2014 Jan; 32(1):174-80. PMID: 24309488.
    Citations: 1     Fields:    Translation:Humans
  155. Shah S, Mehra MR, Couper GS, Desai AS. Continuous flow left ventricular assist device related aortic root thrombosis complicated by left main coronary artery occlusion. J Heart Lung Transplant. 2014 Jan; 33(1):119-20. PMID: 24418738.
    Citations: 2     Fields:    Translation:Humans
  156. O'Meara E, de Denus S, Rouleau JL, Desai A. Circulating biomarkers in patients with heart failure and preserved ejection fraction. Curr Heart Fail Rep. 2013 Dec; 10(4):350-8. PMID: 24122286.
    Citations: 8     Fields:    Translation:HumansCells
  157. Vardeny O, Cavallari LH, Claggett B, Desai AS, Anand I, Rossignol P, Zannad F, Pitt B, Solomon SD. Race influences the safety and efficacy of spironolactone in severe heart failure. Circ Heart Fail. 2013 Sep 01; 6(5):970-6. PMID: 23940307.
    Citations: 6     Fields:    Translation:Humans
  158. Desai AS. Heart failure with preserved ejection fraction: time for a new approach? J Am Coll Cardiol. 2013 Jul 23; 62(4):272-4. PMID: 23684678.
    Citations: 4     Fields:    Translation:HumansAnimals
  159. Weinrauch LA, Desai AS, Skali H, D'Elia JA. Risk stratification of resistant hypertension in chronic kidney disease. J Am Coll Cardiol. 2013 Jun 18; 61(24):2468-2470. PMID: 23623913.
    Citations:    
  160. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau J, Shi VC, Solomon SD, Swedberg K, Zile MR. Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF). Eur J Heart Fail. 2013 Sep; 15(9):1062-73. PMID: 23563576.
    Citations: 43     Fields:    Translation:Humans
  161. Desai AS. Hemoglobin concentration in acute decompensated heart failure: a marker of volume status? J Am Coll Cardiol. 2013 May 14; 61(19):1982-4. PMID: 23500247.
    Citations:    Fields:    Translation:Humans
  162. Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R, Maggioni AP, McMurray JJ, O'Connor C, Pfeffer MA, Solomon SD, Sun Y, Tendera M, van Veldhuisen DJ. Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med. 2013 Mar 28; 368(13):1210-9. PMID: 23473338.
    Citations: 56     Fields:    Translation:Humans
  163. Desai AS. Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are not useful in heart failure management: the art of medicine remains long. Circulation. 2013 Jan 29; 127(4):509-16; discussion 516. PMID: 23357663.
    Citations: 10     Fields:    Translation:Humans
  164. Desai AS, Stevenson LW. There must be a better way: piloting alternate routes around heart failure hospitalizations. J Am Coll Cardiol. 2013 Jan 15; 61(2):127-30. PMID: 23273289.
    Citations: 2     Fields:    Translation:Humans
  165. Shah SJ, Heitner JF, Sweitzer NK, Anand IS, Kim HY, Harty B, Boineau R, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Lewis EF, Markov V, O'Meara E, Kobulia B, Shaburishvili T, Solomon SD, Pitt B, Pfeffer MA, Li R. Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial. Circ Heart Fail. 2013 Mar; 6(2):184-92. PMID: 23258572.
    Citations: 41     Fields:    Translation:Humans
  166. Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA, Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J, Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S, Bertrand M, Fuster V. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012 Dec 20; 367(25):2375-84. PMID: 23121323.
    Citations: 178     Fields:    Translation:Humans
  167. Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Persson F, Desai AS, Nicolaides M, Richard A, Xiang Z, Brunel P, Pfeffer MA. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med. 2012 Dec 06; 367(23):2204-13. PMID: 23121378.
    Citations: 218     Fields:    Translation:Humans
  168. Sharma BK, Bakker JP, McSharry DG, Desai AS, Javaheri S, Malhotra A. Adaptive servoventilation for treatment of sleep-disordered breathing in heart failure: a systematic review and meta-analysis. Chest. 2012 Nov; 142(5):1211-1221. PMID: 22722232.
    Citations: 34     Fields:    Translation:Humans
  169. Vardeny O, Wu DH, Desai A, Rossignol P, Zannad F, Pitt B, Solomon SD. Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study). J Am Coll Cardiol. 2012 Nov 13; 60(20):2082-9. PMID: 23083787.
    Citations: 25     Fields:    Translation:Humans
  170. Weinrauch LA, Desai AS, Lewis EF, D'Elia JA. Ultrafiltration in end-stage heart failure: too little, too late? J Am Coll Cardiol. 2012 Nov 06; 60(19):1913-5. PMID: 23062536.
    Citations:    Fields:    Translation:Humans
  171. Platz E, Lattanzi A, Agbo C, Takeuchi M, Resnic FS, Solomon SD, Desai AS. Utility of lung ultrasound in predicting pulmonary and cardiac pressures. Eur J Heart Fail. 2012 Nov; 14(11):1276-84. PMID: 22962280.
    Citations: 10     Fields:    Translation:Humans
  172. Desai AS, Stevenson LW. Rehospitalization for heart failure: predict or prevent? Circulation. 2012 Jul 24; 126(4):501-6. PMID: 22825412.
    Citations: 90     Fields:    Translation:Humans
  173. Desai AS. The three-phase terrain of heart failure readmissions. Circ Heart Fail. 2012 Jul 01; 5(4):398-400. PMID: 22811548.
    Citations: 8     Fields:    Translation:Humans
  174. Desai AS. Home monitoring heart failure care does not improve patient outcomes: looking beyond telephone-based disease management. Circulation. 2012 Feb 14; 125(6):828-36. PMID: 22331920.
    Citations: 16     Fields:    Translation:Humans
  175. Desai AS, Lewis EF, Li R, Solomon SD, Assmann SF, Boineau R, Clausell N, Diaz R, Fleg JL, Gordeev I, McKinlay S, O'Meara E, Shaburishvili T, Pitt B, Pfeffer MA. Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction. Am Heart J. 2011 Dec; 162(6):966-972.e10. PMID: 22137068.
    Citations: 61     Fields:    Translation:Humans
  176. McMurray JJ, Uno H, Jarolim P, Desai AS, de Zeeuw D, Eckardt KU, Ivanovich P, Levey AS, Lewis EF, McGill JB, Parfrey P, Parving HH, Toto RM, Solomon SD, Pfeffer MA. Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: an analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT). Am Heart J. 2011 Oct; 162(4):748-755.e3. PMID: 21982669.
    Citations: 21     Fields:    Translation:Humans
  177. Ujeyl A, Fang JC, Desai AS, Mudge GH, Givertz MM. Early vitamin C and E supplementation and cardiac allograft vasculopathy: 10-year follow-up from a randomized, controlled study. J Heart Lung Transplant. 2011 Oct; 30(10):1200-1. PMID: 21962021.
    Citations: 1     Fields:    Translation:Humans
  178. Shah AM, Shin SH, Takeuchi M, Skali H, Desai AS, Køber L, Maggioni AP, Rouleau JL, Kelly RY, Hester A, Keefe D, McMurray JJ, Pfeffer MA, Solomon SD. Left ventricular systolic and diastolic function, remodelling, and clinical outcomes among patients with diabetes following myocardial infarction and the influence of direct renin inhibition with aliskiren. Eur J Heart Fail. 2012 Feb; 14(2):185-92. PMID: 21965526.
    Citations: 8     Fields:    Translation:Humans
  179. Shah AM, Lam CS, Cheng S, Verma A, Desai AS, Rocha RA, Hilkert R, Izzo J, Oparil S, Pitt B, Thomas JD, Zile MR, Aurigemma GP, Solomon SD. The relationship between renal impairment and left ventricular structure, function, and ventricular-arterial interaction in hypertension. J Hypertens. 2011 Sep; 29(9):1829-36. PMID: 21799444.
    Citations: 9     Fields:    Translation:Humans
  180. Desai AS, Toto R, Jarolim P, Uno H, Eckardt KU, Kewalramani R, Levey AS, Lewis EF, McMurray JJ, Parving HH, Solomon SD, Pfeffer MA. Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD. Am J Kidney Dis. 2011 Nov; 58(5):717-28. PMID: 21820220.
    Citations: 34     Fields:    Translation:Humans
  181. Pouleur AC, Uno H, Prescott MF, Desai A, Appelbaum E, Lukashevich V, Smith BA, Dahlöf B, Solomon SD. Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertension. J Renin Angiotensin Aldosterone Syst. 2011 Dec; 12(4):483-90. PMID: 21746765.
    Citations: 3     Fields:    Translation:Humans
  182. Punnoose LR, Givertz MM, Lewis EF, Pratibhu P, Stevenson LW, Desai AS. Heart failure with recovered ejection fraction: a distinct clinical entity. J Card Fail. 2011 Jul; 17(7):527-32. PMID: 21703523.
    Citations: 16     Fields:    Translation:Humans
  183. Wade MJ, Desai AS, Spettell CM, Snyder AD, McGowan-Stackewicz V, Kummer PJ, Maccoy MC, Krakauer RS. Telemonitoring with case management for seniors with heart failure. Am J Manag Care. 2011 Mar 01; 17(3):e71-9. PMID: 21504262.
    Citations: 8     Fields:    Translation:Humans
  184. Solomon SD, Shin SH, Shah A, Skali H, Desai A, Kober L, Maggioni AP, Rouleau JL, Kelly RY, Hester A, McMurray JJ, Pfeffer MA. Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction. Eur Heart J. 2011 May; 32(10):1227-34. PMID: 21317148.
    Citations: 32     Fields:    Translation:Humans
  185. Desai AS, Stevenson LW. Connecting the circle from home to heart-failure disease management. N Engl J Med. 2010 Dec 09; 363(24):2364-7. PMID: 21080836.
    Citations: 25     Fields:    Translation:Humans
  186. Pande RL, Park MA, Perlstein TS, Desai AS, Doyle J, Navarrete N, Copeland-Halperin RS, Redline W, Di Carli MF, Creager MA. Impaired skeletal muscle glucose uptake by [18F]fluorodeoxyglucose-positron emission tomography in patients with peripheral artery disease and intermittent claudication. Arterioscler Thromb Vasc Biol. 2011 Jan; 31(1):190-6. PMID: 21051665.
    Citations: 5     Fields:    Translation:Humans
  187. Resnic FS, Desai A. Highlights from the 59th annual scientific sessions of the American College of Cardiology, March 13 to 17, 2010, Atlanta, Georgia. J Thorac Cardiovasc Surg. 2010 Jul; 140(1):257-9. PMID: 20620388.
    Citations:    Fields:    Translation:Humans
  188. Desai A, Lewis E, Solomon S, McMurray JJ, Pfeffer M. Impact of erythropoiesis-stimulating agents on morbidity and mortality in patients with heart failure: an updated, post-TREAT meta-analysis. Eur J Heart Fail. 2010 Sep; 12(9):936-42. PMID: 20525985.
    Citations: 15     Fields:    Translation:Humans
  189. Ross JJ, Britton KA, Desai AS, Stevenson WG. Interactive medical case. The beat goes on. N Engl J Med. 2010 Apr 15; 362(15):e53. PMID: 20397288.
    Citations:    Fields:    Translation:Humans
  190. Buckley O, Doyle L, Padera R, Lakdawala N, Dorbala S, Di Carli M, Kwong R, Desai A, Blankstein R. Cardiomyopathy of uncertain etiology: Complementary role of multimodality imaging with cardiac MRI and 18FDG PET. J Nucl Cardiol. 2010 Apr; 17(2):328-32. PMID: 19777320.
    Citations: 3     Fields:    Translation:Humans
  191. Hancock EW. A crisis in late pregnancy. N Engl J Med. 2010 Mar 04; 362(9):857; author reply 858. PMID: 20200395.
    Citations:    Fields:    Translation:Humans
  192. Shah RV, Desai AS, Givertz MM. The effect of renin-angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis. J Card Fail. 2010 Mar; 16(3):260-7. PMID: 20206902.
    Citations: 24     Fields:    Translation:Humans
  193. Solomon SD, Verma A, Desai A, Hassanein A, Izzo J, Oparil S, Lacourciere Y, Lee J, Seifu Y, Hilkert RJ, Rocha R, Pitt B. Effect of intensive versus standard blood pressure lowering on diastolic function in patients with uncontrolled hypertension and diastolic dysfunction. Hypertension. 2010 Feb; 55(2):241-8. PMID: 19996069.
    Citations: 24     Fields:    Translation:Humans
  194. Desai AS, Chutkow WA, Edelman E, Economy KE, Dec GW. Clinical problem-solving. A crisis in late pregnancy. N Engl J Med. 2009 Dec 03; 361(23):2271-7. PMID: 19955528.
    Citations: 4     Fields:    Translation:Humans
  195. Desai AS. Hyperkalemia in patients with heart failure: incidence, prevalence, and management. Curr Heart Fail Rep. 2009 Dec; 6(4):272-80. PMID: 19948096.
    Citations: 6     Fields:    Translation:Humans
  196. Ross JJ, Desai AS, Chutkow WA, Economy KE, Dec GW. Interactive medical case. A crisis in late pregnancy. N Engl J Med. 2009 Nov 12; 361(20):e45. PMID: 19916244.
    Citations: 1     Fields:    Translation:Humans
  197. Stewart GC, Weintraub JR, Pratibhu PP, Semigran MJ, Camuso JM, Brooks K, Tsang SW, Anello MS, Nguyen VT, Lewis EF, Nohria A, Desai AS, Givertz MM, Stevenson LW. Patient expectations from implantable defibrillators to prevent death in heart failure. J Card Fail. 2010 Feb; 16(2):106-13. PMID: 20142021.
    Citations: 13     Fields:    Translation:Humans
  198. Gelow JM, Desai AS, Hochberg CP, Glickman JN, Givertz MM, Fang JC. Clinical predictors of hepatic fibrosis in chronic advanced heart failure. Circ Heart Fail. 2010 Jan; 3(1):59-64. PMID: 19828874.
    Citations: 12     Fields:    Translation:Humans
  199. Resnic FS, Desai A. Highlights from the 58th Annual Scientific Sessions of the American College of Cardiology, March 28 to 31, 2009, Orlando, Florida. J Thorac Cardiovasc Surg. 2009 Sep; 138(3):795-7. PMID: 19698892.
    Citations:    Fields:    Translation:Humans
  200. Janardhanan R, Desai AS, Solomon SD. Therapeutic approaches to diastolic dysfunction. Curr Hypertens Rep. 2009 Aug; 11(4):283-91. PMID: 19602330.
    Citations: 3     Fields:    Translation:Humans
  201. Hassanein A, Desai A, Verma A, Oparil S, Izzo J, Rocha R, Hilkert R, Seifu Y, Pitt B, Solomon S. EXCEED: Exforge-intensive control of hypertension to evaluate efficacy in diastolic dysfunction: study rationale, design, and participant characteristics. Ther Adv Cardiovasc Dis. 2009 Dec; 3(6):429-39. PMID: 19638366.
    Citations: 2     Fields:    Translation:Humans
  202. Desai AS, Mitchell GF, Fang JC, Creager MA. Central aortic stiffness is increased in patients with heart failure and preserved ejection fraction. J Card Fail. 2009 Oct; 15(8):658-64. PMID: 19786254.
    Citations: 32     Fields:    Translation:Humans
  203. Desai AS, Verma A, Applebaum E, Berglund T, Lukashevich V, Dahlof B, Solomon S, for the ALLAY Investigators. "Pulse Pressure, Aortic Diameter, and Left Ventricular Mass in Patients with Hypertension: A Substudy of the Aliskiren Left Ventricular Assessment of Hypertrophy (ALLAY) Trial". American College of Cardiology 2009 Scientific Sessions, Orlando, FL. 2009.
  204. Desai AS, Lukashevich V, Applebaum E, Smith B, Dahlof B, Solomon S. Hyperkalemia During Treatment of Hypertension with Aliskiren, Losartan, or the Combination: An Analysis of the Aliskiren in Left Ventricular Hypertrophy (ALLAY) Trial. American College of Cardiology 2009 Scientific Sessions, Orlando, FL. 2009.
  205. Desai A. Hyperkalemia associated with inhibitors of the renin-angiotensin-aldosterone system: balancing risk and benefit. Circulation. 2008 Oct 14; 118(16):1609-11. PMID: 18852376.
    Citations: 9     Fields:    Translation:Humans
  206. Resnic FS, Desai A. Highlights from the 57th annual scientific session of the American College of Cardiology. J Thorac Cardiovasc Surg. 2008 Jul; 136(1):244-7. PMID: 18603110.
    Citations:    Fields:    Translation:Humans
  207. Wake N, Desai AS. Images in clinical medicine. Spontaneous thrombolysis of an obstructed mechanical aortic valve. N Engl J Med. 2008 Jun 26; 358(26):e31. PMID: 18579808.
    Citations:    Fields:    Translation:Humans
  208. Mielniczuk LM, Tsang SW, Desai AS, Nohria A, Lewis EF, Fang JC, Baughman KL, Stevenson LW, Givertz MM. The association between high-dose diuretics and clinical stability in ambulatory chronic heart failure patients. J Card Fail. 2008 Jun; 14(5):388-93. PMID: 18514930.
    Citations: 18     Fields:    Translation:Humans
  209. Resnic FS, Desai A. Highlights of the 57th Annual Scientific Session of the American College of Cardiology. Journal of Thoracic and Cardiovascular Surgery. 2008; 136(1):244.
  210. Desai A, Fang JC. Heart failure with preserved ejection fraction: hypertension, diabetes, obesity/sleep apnea, and hypertrophic and infiltrative cardiomyopathy. Heart Fail Clin. 2008 Jan; 4(1):87-97. PMID: 18313627.
    Citations: 10     Fields:    Translation:Humans
  211. Desai AS, Fang JC. "Heart Failure with Normal Ejection Fraction: Diabetes, Hypertension, Obesity/Sleep Apnea, Hypertrophic and Infiltrative CMP". Heart Failure Clinics, eds. Mannan V, Pitt B, Baliga R. 2008; 4(1).
  212. Desai AS, Swedberg K, McMurray JJ, Granger CB, Yusuf S, Young JB, Dunlap ME, Solomon SD, Hainer JW, Olofsson B, Michelson EL, Pfeffer MA, CHARM Investigators. Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program. J Am Coll Cardiol. 2007; 50(20):1959-66.
  213. Desai A. Current understanding of heart failure with preserved ejection fraction. Curr Opin Cardiol. 2007 Nov; 22(6):578-85. PMID: 17921747.
    Citations: 2     Fields:    Translation:Humans
  214. Desai AS, Swedberg K, McMurray JJ, Granger CB, Yusuf S, Young JB, Dunlap ME, Solomon SD, Hainer JW, Olofsson B, Michelson EL, Pfeffer MA. Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program. J Am Coll Cardiol. 2007 Nov 13; 50(20):1959-66. PMID: 17996561.
    Citations: 28     Fields:    Translation:Humans
  215. Desai, Akshay S. Solomon, Scott D. Potential Therapeutic Approaches in Patients with Heart Failure and Preserved Ejection Fraction. Harrison's Online, www.harrisonsonline.com. 2007.
  216. Desai AS, O’Gara P. Critical Care of Pericardial Disease. Irwin and Rippe’s Intensive Care Medicine. 2007.
  217. Lakdawala, Neal Desai, Akshay S. Medical Therapy for Heart Failure. Device Therapy in Heart Failure, Maisel, William H., ed. 2007.
  218. Stevenson LW, Desai AS. Selecting patients for discussion of the ICD as primary prevention for sudden death in heart failure. J Card Fail. 2006 Aug; 12(6):407-12. PMID: 16911905.
    Citations: 12     Fields:    Translation:Humans
  219. Desai AS, Swedberg K, McMurray JJV, Granger CB, Yusuf S, Young JB, Dunlap ME, Solomon SD, Hainer JW, Olofsson B, Michelson EL, Pfeffer MA. . Incidence and Predictors of Hyperkalemia in Patients with Heart Failure – An Analysis of the Candesartan in Heart Failure – Assessment of Reduction in Mortality and Morbidity (CHARM) Program. American College of Cardiology 2006 Scientific Sessions, Atlanta, GA. (Also accepted at European Society of Cardiology – Heart Failure 2006 Conference, Helsinki, Finland). 2006.
  220. Desai AS, Healey JS, Pfeffer MA, Connolly SJ, and Yusuf S, on behalf of the ACTIVE Investigators. Aspirin and the Risk of Heart Failure Hospitalization in Patients with Atrial Fibrillation and a Prior History of Heart Failure: An ACTIVE-W Analysis. Heart Failure Society of America 2006 Scientific Sessions, Seattle, WA, September 2006. 2006.
  221. Desai AS, Koplan B. Device Therapy for Advanced Heart Disease: The Role of Implantable Defibrillators. The Treatment of Advanced Heart Disease. 2006; 301-325.
  222. Desai AS, O'Gara PT. Diabetes and heart failure: epidemiology, pathophysiology and management. Indian Heart J. 2005 Jul-Aug; 57(4):295-303. PMID: 16350674.
    Citations:    Fields:    Translation:Humans
  223. Desai AS, Stone PH. . Secondary Prevention. In Gaziano JM (ed.) Atlas of Cardiovascular Risk Factors Braunwald EB series editor. 2005.
  224. Desai AS, Fang JC, Maisel WH, Baughman KL. Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. JAMA. 2004 Dec 15; 292(23):2874-9. PMID: 15598919.
    Citations: 58     Fields:    Translation:Humans
  225. Gregory SA, Desai AS, Fifer MA. Images in cardiovascular medicine. Isolated right ventricular infarction resulting from occlusion of a nondominant right coronary artery. Circulation. 2004 Nov 16; 110(20):e500-1. PMID: 15545523.
    Citations: 2     Fields:    Translation:Humans
  226. Desai AS, Stone PH. Risk Stratification in Patients with Unstable Angina and Non-ST-elevation Myocardial Infarction. Curr Treat Options Cardiovasc Med. 2004 Feb; 6(1):3-14. PMID: 15023280.
    Citations:    
  227. Gregory S, Desai AS, Fifer MA. Isolated right ventricular infarction due to occlusion of a non-dominant right coronary artery . Circulation. 2004; 110(20):e500-e501.
  228. Desai AS, Stone PH. Risk Stratification in patients with unstable angina and non-ST-elevation myocardial infarction. Curr Treat Options Cardiovasc Med. 2004; 6(1):3-14.
  229. Desai AS, Solomon DH, Stone PH, Avorn J. Economic consequences of routine coronary angiography in low- and intermediate-risk patients with unstable angina pectoris. Am J Cardiol. 2003 Aug 15; 92(4):363-7. PMID: 12914862.
    Citations:    Fields:    Translation:Humans
  230. Desai AS. The 1990 NHS and Community Care Act: the dynamics of political leadership under Mrs. Thatcher. 1994.
  231. Desai AS. Promoting government-NGO cooperation in the Indian health sector: a case study of SEWA-Rural, Jhagadia, Gujarat. 1992.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Desai's Networks
Click the
Explore
buttons for more information and interactive visualizations!